Check out the companies making headlines yesterday:

PacBio (NASDAQ: PACB): Genomics company Pacific Biosciences of California (NASDAQ: PACB) rose by 5.8% on Monday after genomics provider Sampled announced a five-year contract worth up to $27.1 million from the U.S. Department of Veterans Affairs to support research using PacBio Revio sequencing systems. See our full article here.

Is now the time to buy PacBio? Access our full analysis report here, it’s free.

Nvidia (NASDAQ: NVDA): Leading designer of graphics chips Nvidia (NASDAQ: NVDA) rose by 2.7% on Monday after the company authorized an additional $150 billion for its share buyback program, taking the total authorization to $235 billion. See our full article here.

Is now the time to buy Nvidia? Access our full analysis report here, it’s free.

Palo Alto Networks (NASDAQ: PANW): Cybersecurity platform provider Palo Alto Networks (NASDAQ: PANW) rose by 5.1% on Monday after BTIG raised its price target on the company to $425 from $404 and reiterated a Buy rating following discussions with management. See our full article here.

Is now the time to buy Palo Alto Networks? Access our full analysis report here, it’s free.

Teleflex (NYSE: TFX): Medical technology company Teleflex (NYSE: TFX) rose by 4.5% on Monday after BofA Securities upgraded the stock from Neutral to Buy and raised its price target. See our full article here.

Is now the time to buy Teleflex? Access our full analysis report here, it’s free.